Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated <i>in silico</i> , <i>in vitro</i> , and <i>in vivo</i> evaluation of DPP-4 inhibition and hepatic enzyme modulation

Authors

Institutions

Publication Details

Journal
Future Medicinal Chemistry
Published
2026-02-26
DOI
https://doi.org/10.1080/17568919.2026.2636821
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico , in vitro , and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation

Ahlam Abdulrahman Alrashdi, Ismail Daoud, Sarra Boudriga, Dalal Alardan et al.
Future Medicinal Chemistry
Diabetes Treatment and Management
article

Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico , in vitro , and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation

Ahlam Abdulrahman Alrashdi, Ismail Daoud, Sarra Boudriga, Dalal Alardan, Faiza I A Abdella, Nawal S Alshammari
article en

Abstract

No abstract available for this paper.
Future Medicinal Chemistry
University of Monastir (TN), University of Biskra (DZ), University of Abou Bekr Belkaïd (DZ), University of Ha'il (SA), Dynamic Systems (United States) (US)
Good health and well-being
Openalex Percentile: Top 43%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.